Number of deals: 41
Number of companies: 31
Scoop: One of the most well-known names in biotech venture capital, Domain Associates was founded in 1985 and has had its hand in the formation of more than 210 companies since then. The firm invests only in life science companies and, according to its website, prefers "to be a part of the first institutional financing round of the company." In addition to private investing, Domain Associates will also become involved with select public companies, where the firm will take a seat on the company's board and become involved in the company's strategy.
Just yesterday Domain announced the closing of Domain Partners VIII, a $500 million venture capital fund. Over the past 24 years Domain has raised funds totaling $2.7 billion. Its portfolio companies include Align, BiPar (sold to Sanofi), Onxy Pharmacuticles, NuVasive, Vanda, and many more.
Portfolio Company News:
Clovis Oncology - 2009 Fierce 15
Achaogen - 2009 Fierce 15
Cadence Pharma pockets $86M in placement
Oraya garners $42M in third venture round
Pharmion alum snag $145M for cancer deals
Evoke Pharma gathers funds, stays under radar